Skip to main content
MedPathMedPath Home
Clinical Trials/PER-013-02
PER-013-02
Completed
未知

SUPPLEMENTATION WITH CALCIUM FOR THE PREVENTION OF PRE-ECLAMPSIA IN WOMEN WITH LOW CALCIUM INTAKE

INSTITUTO DE INVESTIGACION NUTRICIONAL,0 sites0 target enrollmentJanuary 23, 2002
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions-O149 Pre-eclampsia, unspecifiedPre-eclampsia, unspecifiedO149

Overview

Phase
未知
Intervention
Not specified
Conditions
-O149 Pre-eclampsia, unspecified
Sponsor
INSTITUTO DE INVESTIGACION NUTRICIONAL,
Status
Completed
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 23, 2002
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
INSTITUTO DE INVESTIGACION NUTRICIONAL,

Eligibility Criteria

Inclusion Criteria

  • •Pregnant women who attend prenatal care in the participating centers will be eligible if they meet the following criteria:
  • •1\. Gestational age \<20 weeks
  • •2\. Nulliparous
  • •3\. Disposition and capacity to give consent (for minors, informed consent will be obtained following the age limits specified by country).

Exclusion Criteria

  • •History of urolithiasis or symptoms suggestive of urolithiasis or any kidney disease, such as hematuria, pain in the flanks, etc.
  • •Parathyroid disease.
  • •Systolic blood pressure greater than or equal to 140 mmHg and / or diastolic greater than or equal to 90 mmHg,
  • •Taking diuretics or any treatment with digoxin.
  • •Plan to give birth at a health service outside the area or at home.
  • •Taking phenytoin or tetracycline.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Phase 3
Calcium supplementation for prevention of pre-eclampsiaPrevention of pre-eclampsia in women at increased riskPregnancy and ChildbirthPre-eclampsia
ISRCTN12033893niversity of Birmingham7,756
Terminated
Phase 3
Calcium and Aspirin Supplementation for Prevention of Preeclampsia (in High Risk Pregnancy)Pregnant women with one or more high risk and women with two or more moderate risk of developing preeclampsiacalcium carbonatepre-eclampsiaprevention
TCTR20221001001/A130
Not yet recruiting
Not Applicable
se of calcium carbonate supplementation to prevent Pre-eclampsia in pregnant women high risk:randomized clinical trialnspecified pre-eclampsiaC12.050.703.634
RBR-7hqhj3yCentro de Ciências Biológicas e da Saúde - Universidade Federal de Sergipe
Completed
Not Applicable
Effects of calcium in the prevention of ovarian hyperstimulation syndrome in patients undergoing IVF/ICSIovarian hyperstimulation.Hyperstimulation of ovaries
IRCT2016071428930N1Vice Chancellor Of Research, Mashhad University of Medical Sciences186
Completed
Not Applicable
Vitamin D supplementation for childre
CTRI/2018/02/012187Indian Council of Medical Research ICMR300